-

cbdMD, Inc. To Host Conference Call To Discuss First Quarter 2020 Results

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD PR A ), a nationally recognized consumer cannabidiol (CBD) brand, announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Thursday, February 13, 2020, to discuss the company’s first quarter of fiscal 2020 financial results and business progress.

CONFERENCE CALL DETAILS

Thursday, February 13, 2020, 4:15 p.m. Eastern Time

Domestic:

1-844-407-9500

International:

1-862-298-0850

Replay dial in – Available through March 13, 2020

Domestic:

1-877-481-4010

International:

1-919-882-2331

Replay ID:

58733

Webcast Replay link – available through May 13, 2020:

https://www.investornetwork.com/event/presentation/5733

About cbdMD, Inc.

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) owns and operates the nationally recognized consumer cannabidiol (CBD) brand cbdMD whose current products include CBD tinctures, CBD gummies, CBD topical, CBD bath bombs, CBD oils, and CBD pet products.

Contacts

Investors:
John Weston, 704-445-3060 ext 1103
John.weston@cbdmd.com

Industry:

cbdMD, Inc.

NYSEAM:YCBD
Release Versions
English

Contacts

Investors:
John Weston, 704-445-3060 ext 1103
John.weston@cbdmd.com

More News From cbdMD, Inc.

cbdMD™ Makes History Becoming the First CBD Brand to Achieve 3 NSF’s Certified for Sport® Certifications

CHARLOTTE, N.C.--(BUSINESS WIRE)--New suite of products allows professionals from all walks of life to add CBD to their regimen without fear of failing a drug test for THC....

cbdMD Expands Product Offering and Nationwide Footprint with Major Retail Partner GNC

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), (the “Company”) one of the world’s leading and most highly trusted and recognized health & wellness CBD companies, has announced an expansion in product offerings online and in over 840 retail GNC Holdings, LLC (GNC) stores nationwide. cbdMD first partnered with GNC in August 2020, and included a roll-out of three topical SKUs at under 100 retail stores nationwide. Due to consumer receptivity and overall purchasing...

cbdMD Requests the Food and Drug Administration (FDA) Remove the Drug Exclusion for CBD and Review cbdMD’s Extensive Safety Submission

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the world’s leading and most highly trusted and recognized health & wellness CBD companies, today announced that the Natural Products Association (NPA) filed a Citizen’s Petition on cbdMD’s behalf with the Food and Drug Administration (FDA) requesting the FDA to remove the drug exclusion for CBD and to review the Company’s extensive dossier of identity, safety and quality data. Removing the d...
Back to Newsroom